BOHLEN ELIZABETH 4
4 · Insys Therapeutics, Inc. · Filed Apr 23, 2019
Insider Transaction Report
Form 4
BOHLEN ELIZABETH
Director
Transactions
- Award
Employee Stock Option (right to buy)
2019-03-04+20,935→ 20,935 totalExercise: $6.36Exp: 2029-03-03→ Common Stock (20,935 underlying) - Award
Common Stock
2019-03-04+8,083→ 14,083 total
Footnotes (1)
- [F1]The option vests in 36 equal monthly installments and will be fully vested and exercisable on March 4, 2022.